Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Indian J Ophthalmol ; 70(5): 1833-1836, 2022 05.
Article in English | MEDLINE | ID: covidwho-1835132

ABSTRACT

Multiple sclerosis and neuromyelitis optica spectrum disorder may be seen in the acute setting of coronavirus disease 2019 (COVID-19) infection or even post-recovery. Such patients may present with optic neuropathy along with weakness in the back and lower limbs. Ascending paralysis can present with respiratory distress in acute COVID-19 infection and may even prove to be fatal. We report a unique case of a 16-year-old female with past history of COVID-19 infection having optic neuropathy, and radioimaging showing demyelinating plaques in the central nervous system with spinal cord edema. Serology showed positivity for rheumatoid arthritis, and the patient was managed with steroids and rituximab.


Subject(s)
COVID-19 , Multiple Sclerosis , Neuromyelitis Optica , Adolescent , COVID-19/complications , Female , Humans , Neuromyelitis Optica/complications , Neuromyelitis Optica/diagnosis , Optic Nerve , Rituximab
2.
Cornea ; 41(2): 254-256, 2022 Feb 01.
Article in English | MEDLINE | ID: covidwho-1636854

ABSTRACT

ABSTRACT: As the understanding of COVID-19 infection becomes better, it is being recognized as a complex multisystem pathology rather than just affecting the lungs. Several ocular findings have been documented by researchers in individuals infected with COVID-19, and ocular symptoms may even be the first presenting feature of COVID-19 infection in 2.26% individuals. Several countries have started vaccination with inactivated or live vaccines to combat this pandemic, and varied side effects have been reported after vaccination. Few cases of herpes zoster have previously been reported in elderly patients with comorbidities after receiving COVID-19 vaccines. In this article, the authors described 2 interesting cases of herpes zoster ophthalmicus (HZO) after receiving a live COVID-19 vaccine. The first case was a 35-year-old immunocompetent man who developed HZO 3 days postvaccine. The second case was a 40-year-old immunocompetent man who developed HZO 28 days postvaccine. To the best of our knowledge, no literature to date has described HZO after live vaccine.


Subject(s)
COVID-19/prevention & control , ChAdOx1 nCoV-19/adverse effects , Conjunctivitis, Viral/etiology , Herpes Zoster Ophthalmicus/etiology , Vaccination/adverse effects , Acyclovir/therapeutic use , Administration, Ophthalmic , Administration, Oral , Adult , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Conjunctivitis, Viral/diagnosis , Conjunctivitis, Viral/drug therapy , Drug Therapy, Combination , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy , Humans , Male , Moxifloxacin/therapeutic use , SARS-CoV-2/immunology , Valacyclovir/therapeutic use , Visual Acuity/physiology
3.
Indian J Ophthalmol ; 69(3): 701-705, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1089038

ABSTRACT

PURPOSE: The aim of this study was to evaluate the changing trends in terms of patient load, presenting complaints, surgical procedures and resource utilization in a multispeciality tertiary care hospital after lockdown due to COVID-19. METHODS: Retrospective.data were collected from Ophthalmology in-patient and emergency services of a government medical college and multispecialty tertiary care hospital in North India. Data pertaining to patient census, presenting complaints, surgical procedures and resource consumption were compared in the 6-month period (March 25 to September 30, 2020) following national lockdown and subsequent gradual unlock to data of same time period last year. RESULTS: A total of 1152 new patients visited Ophthalmology emergency service, whereas 324 sought tele-ophthalmology consultation.Majority were males (61.8%, n = 712), whereas average age of presentation was 34 ± 7.2 years. The number.of patients seeking emergency ophthalmic care reduced by 23.9% in the current year, in-patient record reduced by 96.53% and number of surgeries reduced by 98.13%. Tele-ophthalmology services comprised 21.95% of the total patient load. Use of triple layered surgical masks increased by 85.7%, use of disposable gloves increased by 89.5% but interestingly the availability of chlorhexidine hand rub fell by 15.9%, in the current year compared to last year. CONCLUSION: COVID-19 pandemic and lockdown have reduced the number of patients visiting tertiary health care facility for ophthalmic care. As manpower and resource consumption has increased, smart management is needed to tackle the current scenario efficiently. Tele-ophthalmology must be promoted and we must understand the changing trends to plan for the future accordingly.


Subject(s)
COVID-19/epidemiology , Communicable Disease Control/organization & administration , Emergency Medical Services/organization & administration , Eye Diseases/epidemiology , Ophthalmology/trends , Quarantine , SARS-CoV-2 , Comorbidity , Emergencies , Female , Humans , India/epidemiology , Male , Pandemics , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL